Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 308.20M
March 31, 2026 338.18M
December 31, 2025 372.15M
September 30, 2025 421.68M
June 30, 2025 342.23M
March 31, 2025 322.76M
December 31, 2024 383.33M
September 30, 2024 380.34M
June 30, 2024 473.16M
March 31, 2024 410.76M
December 31, 2023 368.22M
September 30, 2023 355.22M
June 30, 2023 363.26M
March 31, 2023 465.06M
December 31, 2022 431.67M
September 30, 2022 396.26M
June 30, 2022 370.09M
March 31, 2022 345.53M
December 31, 2021 223.54M
September 30, 2021 361.33M
June 30, 2021 369.98M
March 31, 2021 372.96M
December 31, 2020 440.70M
September 30, 2020 428.79M
June 30, 2020 405.36M
Date Value
March 31, 2020 307.32M
December 31, 2019 275.96M
September 30, 2019 231.64M
June 30, 2019 201.54M
March 31, 2019 186.90M
December 31, 2018 206.76M
September 30, 2018 195.19M
June 30, 2018 159.94M
March 31, 2018 125.36M
December 31, 2017 88.74M
September 30, 2017 75.16M
June 30, 2017 66.16M
March 31, 2017 52.77M
December 31, 2016 51.54M
September 30, 2016 47.86M
June 30, 2016 41.79M
March 31, 2016 40.74M
December 31, 2015 40.44M
September 30, 2015 36.45M
June 30, 2015 37.05M
March 31, 2015 37.95M
December 31, 2014 24.25M
September 30, 2014 26.78M
June 30, 2014 33.97M
March 31, 2014 43.62M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 284.18M
Eli Lilly & Co. 8.95B
Abeona Therapeutics, Inc. 146.83M
Indivior Pharmaceuticals, Inc. 222.00M
Crinetics Pharmaceuticals, Inc. 1.206B